These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 18451592)

  • 1. [Investigation of susceptibility testing methods for micafungin: comparison of two microdilution methods].
    Abe M; Ogawa Z; Tanuma H; Yamazaki T; Kume H
    Nihon Ishinkin Gakkai Zasshi; 2008; 49(2):111-8. PubMed ID: 18451592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifungal activity of micafungin against Candida and Aspergillus spp. isolated from pediatric patients in Japan.
    Ikeda F; Saika T; Sato Y; Suzuki M; Hasegawa M; Mikawa T; Kobayashi I; Tsuji A
    Med Mycol; 2009 Mar; 47(2):145-8. PubMed ID: 18668422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of two methods and three end points in determination of in vitro activity of micafungin against Aspergillus spp.
    Arikan S; Yurdakul P; Hascelik G
    Antimicrob Agents Chemother; 2003 Aug; 47(8):2640-3. PubMed ID: 12878531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies on the correlation of the method currently used by the Japanese Society for Medical Mycology and its modified method with the NCCLS M27-A2 microdilution method for azole susceptibility testing of Candida species].
    Uchida K; Nishiyama Y; Yamaguchi H
    Nihon Ishinkin Gakkai Zasshi; 2006; 47(3):209-17. PubMed ID: 16940956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hypoxic conditions on in vitro susceptibility testing of amphotericin B, itraconazole and micafungin against Aspergillus and Candida.
    Warn PA; Sharp A; Guinea J; Denning DW
    J Antimicrob Chemother; 2004 May; 53(5):743-9. PubMed ID: 15044422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of MICs of aminocandin for Candida spp. and filamentous fungi.
    Isham N; Ghannoum MA
    J Clin Microbiol; 2006 Dec; 44(12):4342-4. PubMed ID: 17021057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative study of disc diffusion and microdilution methods in susceptibility testing of micafungin against Candida species.
    Ramírez M; Serrano MC; Castro C; López E; Almeida C; Fernández A; Romero A; Martín-Mazuelos E
    J Antimicrob Chemother; 2006 Oct; 58(4):861-3. PubMed ID: 16916868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species.
    Odds FC; Motyl M; Andrade R; Bille J; Cantón E; Cuenca-Estrella M; Davidson A; Durussel C; Ellis D; Foraker E; Fothergill AW; Ghannoum MA; Giacobbe RA; Gobernado M; Handke R; Laverdière M; Lee-Yang W; Merz WG; Ostrosky-Zeichner L; Pemán J; Perea S; Perfect JR; Pfaller MA; Proia L; Rex JH; Rinaldi MG; Rodriguez-Tudela JL; Schell WA; Shields C; Sutton DA; Verweij PE; Warnock DW
    J Clin Microbiol; 2004 Aug; 42(8):3475-82. PubMed ID: 15297486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro antifungal activity of FK463, a new water-soluble echinocandin-like lipopeptide.
    Mikamo H; Sato Y; Tamaya T
    J Antimicrob Chemother; 2000 Sep; 46(3):485-7. PubMed ID: 10980180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Etest method for susceptibility testing of Aspergillus spp. and Fusarium spp. to three echinocandins.
    Martos AI; Romero A; González MT; González A; Serrano C; Castro C; Pemán J; Cantón E; Martín-Mazuelos E
    Med Mycol; 2010 Sep; 48(6):858-61. PubMed ID: 20144131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antifungal activities of anidulafungin and micafungin, licensed agents and the investigational triazole posaconazole as determined by NCCLS methods for 12,052 fungal isolates: review of the literature.
    Espinel-Ingroff A
    Rev Iberoam Micol; 2003 Dec; 20(4):121-36. PubMed ID: 15456349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of clinical isolates of Aspergillus spp. to anidulafungin, caspofungin, and micafungin: a head-to-head comparison using the CLSI M38-A2 broth microdilution method.
    Pfaller MA; Boyken L; Hollis RJ; Kroeger J; Messer SA; Tendolkar S; Diekema DJ
    J Clin Microbiol; 2009 Oct; 47(10):3323-5. PubMed ID: 19710267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A study for testing the antifungal susceptibility of yeast by the Japanese Society for Medical Mycology (JSMM) method. The proposal of the modified JSMM method 2009].
    Nishiyama Y; Abe M; Ikeda R; Uno J; Oguri T; Shibuya K; Maesaki S; Mohri S; Yamada T; Ishibashi H; Hasumi Y; Abe S
    Nihon Ishinkin Gakkai Zasshi; 2010; 51(3):153-63. PubMed ID: 20716854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Susceptibility to echinocandins of Candida spp. strains isolated in Italy assessed by European Committee for Antimicrobial Susceptibility Testing and Clinical Laboratory Standards Institute broth microdilution methods.
    Montagna MT; Lovero G; Coretti C; Martinelli D; De Giglio O; Iatta R; Balbino S; Rosato A; Caggiano G
    BMC Microbiol; 2015 May; 15():106. PubMed ID: 25990252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of fluorescent probes to determine MICs of amphotericin B and caspofungin against Candida spp. and Aspergillus spp.
    Peter J; Armstrong D; Lyman CA; Walsh TJ
    J Clin Microbiol; 2005 Aug; 43(8):3788-92. PubMed ID: 16081911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of spectrophotometric reading for in vitro antifungal susceptibility testing of Aspergillus spp.
    Dannaoui E; Persat F; Monier MF; Borel E; Piens MA; Picot S
    Can J Microbiol; 1999 Oct; 45(10):871-4. PubMed ID: 10907424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of voriconazole combined with micafungin against Candida, Aspergillus, and Scedosporium spp. and Fusarium solani.
    Heyn K; Tredup A; Salvenmoser S; Müller FM
    Antimicrob Agents Chemother; 2005 Dec; 49(12):5157-9. PubMed ID: 16304192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Antifungal activity and clinical efficacy of micafungin (funguard)].
    Ikeda F
    Nihon Ishinkin Gakkai Zasshi; 2005; 46(4):217-22. PubMed ID: 16282962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro pharmacodynamics of caspofungin, micafungin, and anidulafungin against germinated and nongerminated Aspergillus conidia.
    Antachopoulos C; Meletiadis J; Sein T; Roilides E; Walsh TJ
    Antimicrob Agents Chemother; 2008 Jan; 52(1):321-8. PubMed ID: 17938191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.